ABVC BIOPHARMA, INC. (ABVC): Nasdaq/NYSE listing notice — ABVC BioPharma gets Nasdaq extension to comply with equity rule; deadline August 31, 2023

ABVC BIOPHARMA, INC.

Received deficiency letter on May 26, 2023 for non-compliance with minimum stockholders' equity requirement.
Nasdaq granted extension on July 10, 2023 to comply with Listing Rule 5550(b)(1) by August 31, 2023.
Failure to evidence compliance upon filing Q3 2023 periodic report may lead to delisting from Nasdaq.
Common stock continues trading under symbol ABVC on Nasdaq Capital Market while appeal rights exist.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ABVC BIOPHARMA, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

July 10, 2023,Nasdaq granted the Company an extension to comply with Listing Rule 5550(b)(1). The Company must now achieve compliance with this rule on or before August 31, 2023. If the Company fails to evidence compliance upon filing its periodic report for the quarter ending September 30, 2023, the Company may be subject to delisting. If Nasdaq determines to delist the Company’s securities, the Company will have an opportunity to appeal Nasdaq’s decision. At this time, the Company’s Common Stock will continue to trade on The Nasdaq Capital Market under the symbol “ABVC”. SIGNATURE Pursuant t

View on SEC.gov

Browse all listing & compliance notices →

ABVC BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001213900-23-057137

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.